Header Logo

Giselle Mosnaim

Concepts (261)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
52
2023
162
14.760
Why?
Anti-Asthmatic Agents
17
2023
34
5.120
Why?
Hypersensitivity
7
2023
48
2.700
Why?
Adrenal Cortex Hormones
13
2023
117
2.610
Why?
Physicians
6
2022
123
2.600
Why?
Telemedicine
7
2023
119
2.460
Why?
Medication Adherence
12
2023
81
2.310
Why?
Patient Education as Topic
9
2021
160
2.290
Why?
Burnout, Professional
4
2022
41
2.270
Why?
Coronavirus Infections
7
2020
90
1.970
Why?
Pneumonia, Viral
7
2020
94
1.960
Why?
Child
29
2023
1423
1.560
Why?
Humans
79
2023
28560
1.500
Why?
Community Health Workers
7
2022
35
1.400
Why?
Administration, Inhalation
14
2022
45
1.320
Why?
Adolescent
24
2023
2319
1.160
Why?
Pandemics
11
2022
260
1.080
Why?
Behavior Therapy
2
2017
92
0.990
Why?
Caregivers
7
2019
203
0.940
Why?
Nebulizers and Vaporizers
8
2022
25
0.910
Why?
Mobile Applications
2
2020
32
0.820
Why?
Betacoronavirus
5
2020
77
0.800
Why?
Emergency Service, Hospital
8
2020
259
0.780
Why?
Biological Products
1
2022
45
0.740
Why?
Environmental Exposure
2
2018
17
0.700
Why?
Allergy and Immunology
4
2020
5
0.700
Why?
Monitoring, Ambulatory
1
2020
19
0.690
Why?
Poverty
3
2020
100
0.670
Why?
Surveys and Questionnaires
8
2022
1220
0.640
Why?
Adult
20
2023
8168
0.630
Why?
Parents
2
2018
126
0.610
Why?
Emigrants and Immigrants
2
2018
24
0.610
Why?
Respiratory Tract Diseases
1
2018
7
0.600
Why?
Physician-Patient Relations
1
2018
43
0.600
Why?
Health Literacy
4
2021
109
0.580
Why?
Registries
1
2019
188
0.580
Why?
Female
31
2023
15818
0.580
Why?
Male
30
2023
15400
0.560
Why?
Self Care
5
2020
105
0.560
Why?
Decision Making
1
2018
229
0.520
Why?
Assertiveness
1
2015
8
0.510
Why?
Child, Preschool
8
2022
690
0.510
Why?
Urban Population
5
2013
158
0.470
Why?
Chicago
7
2019
939
0.450
Why?
United States
9
2023
2197
0.430
Why?
Social Support
2
2021
215
0.430
Why?
Family
3
2021
115
0.420
Why?
Bronchodilator Agents
3
2022
21
0.420
Why?
Immunization, Passive
5
2023
14
0.410
Why?
Patient Compliance
2
2011
164
0.410
Why?
MP3-Player
2
2013
5
0.410
Why?
Minority Groups
4
2019
87
0.400
Why?
House Calls
3
2021
22
0.380
Why?
Electronics
2
2021
11
0.370
Why?
Fellowships and Scholarships
2
2022
44
0.360
Why?
Health Services Accessibility
2
2023
110
0.360
Why?
Computer Security
2
2020
6
0.350
Why?
Insurance, Health, Reimbursement
2
2020
18
0.350
Why?
Socioeconomic Factors
5
2021
308
0.340
Why?
Health Knowledge, Attitudes, Practice
2
2011
185
0.340
Why?
Stress Disorders, Post-Traumatic
4
2021
235
0.330
Why?
Asthma, Exercise-Induced
1
2009
1
0.320
Why?
Hospitalization
3
2022
322
0.320
Why?
Adrenergic beta-Agonists
1
2009
16
0.320
Why?
Athletes
1
2009
89
0.290
Why?
Communication Barriers
1
2007
4
0.290
Why?
Adaptation, Psychological
2
2020
183
0.290
Why?
Language
1
2007
71
0.280
Why?
Quality Improvement
3
2018
161
0.280
Why?
Research Design
2
2019
208
0.270
Why?
Electronic Health Records
3
2020
75
0.240
Why?
Severity of Illness Index
5
2021
990
0.230
Why?
Monitoring, Physiologic
2
2022
76
0.220
Why?
Albuterol
4
2022
19
0.220
Why?
Urticaria
1
2023
4
0.220
Why?
Transfusion Reaction
1
2023
7
0.220
Why?
One Health
1
2023
1
0.220
Why?
Patient Preference
1
2023
33
0.210
Why?
Social Determinants of Health
1
2023
32
0.210
Why?
Middle Aged
8
2022
9316
0.210
Why?
Glucocorticoids
2
2020
70
0.210
Why?
Health Status Disparities
1
2023
74
0.200
Why?
Vaccines, Synthetic
1
2022
3
0.200
Why?
Adaptive Immunity
1
2022
18
0.200
Why?
Vaccination
1
2022
31
0.190
Why?
Delivery of Health Care
2
2020
153
0.190
Why?
Antibodies, Viral
1
2022
53
0.190
Why?
Pulmonary Disease, Chronic Obstructive
1
2022
53
0.190
Why?
Anaphylaxis
1
2021
11
0.190
Why?
Endpoint Determination
1
2021
22
0.180
Why?
Biomedical Technology
1
2021
8
0.180
Why?
Treatment Outcome
7
2022
3620
0.180
Why?
Cross-Sectional Studies
6
2021
935
0.180
Why?
Practice Patterns, Physicians'
2
2019
122
0.180
Why?
Feedback
1
2020
33
0.180
Why?
Remote Sensing Technology
1
2020
3
0.180
Why?
Comparative Effectiveness Research
2
2021
6
0.180
Why?
Clinical Coding
1
2020
5
0.180
Why?
Confidentiality
1
2020
7
0.180
Why?
Mental Health
2
2020
122
0.180
Why?
Self-Management
2
2017
14
0.180
Why?
Tiotropium Bromide
1
2020
2
0.170
Why?
Adrenergic beta-2 Receptor Agonists
1
2020
4
0.170
Why?
Desensitization, Immunologic
1
2020
4
0.170
Why?
Self Report
1
2021
226
0.170
Why?
Depression
3
2020
454
0.170
Why?
Clinical Trials as Topic
2
2021
239
0.170
Why?
Lung
1
2021
170
0.170
Why?
Ambulatory Care Facilities
1
2020
40
0.170
Why?
Delivery of Health Care, Integrated
1
2020
25
0.170
Why?
Symptom Flare Up
1
2019
2
0.170
Why?
Health Care Costs
1
2020
80
0.160
Why?
Family Relations
1
2019
14
0.160
Why?
Double-Blind Method
3
2023
433
0.160
Why?
Societies, Medical
1
2020
154
0.160
Why?
Residence Characteristics
2
2019
214
0.160
Why?
Office Visits
1
2019
13
0.160
Why?
Infection Control
1
2020
166
0.160
Why?
Documentation
1
2019
29
0.160
Why?
Pediatrics
1
2019
46
0.150
Why?
Patient Acceptance of Health Care
1
2019
81
0.150
Why?
Outpatients
3
2023
59
0.150
Why?
Occupational Exposure
1
2018
17
0.150
Why?
Patient Participation
1
2018
53
0.150
Why?
Prevalence
2
2018
467
0.150
Why?
Randomized Controlled Trials as Topic
2
2023
329
0.140
Why?
Volunteers
1
2017
5
0.140
Why?
Community Participation
1
2017
18
0.140
Why?
Precision Medicine
1
2017
29
0.140
Why?
Education, Distance
1
2017
18
0.140
Why?
Cell Phone
1
2017
7
0.140
Why?
Risk Factors
4
2021
2412
0.140
Why?
Patient Transfer
1
2016
23
0.140
Why?
Community Mental Health Services
1
2015
19
0.130
Why?
Smartphone
1
2015
17
0.120
Why?
Health Status
3
2021
226
0.120
Why?
Patient Reported Outcome Measures
1
2019
507
0.120
Why?
Retrospective Studies
2
2022
3612
0.110
Why?
Peer Group
1
2013
40
0.110
Why?
Housing
1
2013
19
0.110
Why?
Risk Assessment
3
2021
677
0.100
Why?
Drug Therapy, Combination
3
2020
184
0.100
Why?
Animals
2
2023
3812
0.100
Why?
Quality of Life
3
2023
659
0.100
Why?
Obesity
2
2019
321
0.100
Why?
Vagus Nerve Stimulation
1
2012
8
0.100
Why?
Young Adult
4
2022
2102
0.100
Why?
Chronic Disease
1
2013
442
0.100
Why?
Pilot Projects
2
2017
440
0.100
Why?
Aged
3
2022
9334
0.100
Why?
School Health Services
1
2011
21
0.090
Why?
Social Class
1
2011
66
0.090
Why?
Chi-Square Distribution
1
2011
146
0.090
Why?
Age Factors
1
2013
788
0.090
Why?
Students
1
2011
53
0.090
Why?
Mexican Americans
1
2011
29
0.090
Why?
Consensus
2
2021
98
0.090
Why?
Ambulatory Care
2
2022
74
0.090
Why?
Anti-Allergic Agents
1
2010
2
0.090
Why?
Androstadienes
1
2010
7
0.090
Why?
Rhinitis, Allergic, Seasonal
1
2010
5
0.090
Why?
Quinolines
1
2010
8
0.090
Why?
Acetates
1
2010
17
0.080
Why?
Puerto Rico
3
2014
13
0.080
Why?
Anxiety
2
2021
161
0.080
Why?
Allergens
2
2023
16
0.080
Why?
Respiratory Function Tests
1
2009
36
0.080
Why?
Disease Progression
2
2022
722
0.080
Why?
Logistic Models
2
2019
396
0.070
Why?
Music
1
2008
24
0.070
Why?
Drug Combinations
2
2021
36
0.070
Why?
Emigration and Immigration
1
2006
15
0.070
Why?
Forced Expiratory Volume
2
2019
11
0.070
Why?
Interleukin-8
1
2023
19
0.050
Why?
Interleukin-7
1
2023
12
0.050
Why?
Antibodies
1
2023
49
0.050
Why?
Irritants
1
2023
1
0.050
Why?
Prospective Studies
2
2023
1807
0.050
Why?
Community-Based Participatory Research
2
2014
43
0.050
Why?
Syndrome
1
2023
82
0.050
Why?
Vascular Endothelial Growth Factor A
1
2023
72
0.050
Why?
Post-Exposure Prophylaxis
1
2023
3
0.050
Why?
Dry Powder Inhalers
1
2022
3
0.050
Why?
Metered Dose Inhalers
1
2022
5
0.050
Why?
Patients
1
2022
35
0.050
Why?
Bayes Theorem
1
2022
43
0.050
Why?
Cytokines
1
2023
231
0.050
Why?
Inflammation
1
2023
288
0.050
Why?
RNA, Viral
1
2021
45
0.050
Why?
Stakeholder Participation
1
2021
10
0.050
Why?
Population Surveillance
1
2022
110
0.050
Why?
Review Literature as Topic
1
2021
12
0.050
Why?
Delphi Technique
1
2021
27
0.050
Why?
Substance-Related Disorders
2
2020
97
0.040
Why?
Qualitative Research
1
2021
126
0.040
Why?
London
1
2020
2
0.040
Why?
Terbutaline
1
2020
1
0.040
Why?
United Kingdom
1
2020
51
0.040
Why?
Self Administration
1
2020
22
0.040
Why?
Professionalism
1
2020
4
0.040
Why?
Health Care Rationing
1
2020
6
0.040
Why?
Markov Chains
1
2020
32
0.040
Why?
Immunologic Deficiency Syndromes
1
2020
8
0.040
Why?
Guilt
1
2020
5
0.040
Why?
Efficiency
1
2020
20
0.040
Why?
Suicide
1
2020
15
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
21
0.040
Why?
Grief
1
2020
19
0.040
Why?
Cost-Benefit Analysis
1
2020
134
0.040
Why?
Community Health Services
1
2020
35
0.040
Why?
Social Behavior
1
2020
72
0.040
Why?
Dose-Response Relationship, Drug
1
2020
352
0.040
Why?
Mindfulness
1
2020
48
0.040
Why?
Spirituality
1
2020
80
0.040
Why?
Administration, Oral
1
2019
111
0.040
Why?
ROC Curve
1
2019
144
0.040
Why?
Healthcare Disparities
1
2020
85
0.040
Why?
Proportional Hazards Models
1
2020
352
0.040
Why?
Social Media
1
2020
50
0.040
Why?
Communication
1
2020
124
0.040
Why?
Health Care Surveys
1
2019
66
0.040
Why?
Curriculum
1
2020
164
0.040
Why?
Health Promotion
1
2020
162
0.040
Why?
Smoking
1
2019
176
0.040
Why?
Odds Ratio
1
2019
268
0.040
Why?
Educational Status
1
2019
298
0.040
Why?
Persuasive Communication
1
2017
1
0.030
Why?
Focus Groups
1
2017
93
0.030
Why?
Comorbidity
1
2019
501
0.030
Why?
Likelihood Functions
1
2017
27
0.030
Why?
Follow-Up Studies
1
2022
1863
0.030
Why?
Sinusitis
1
2019
161
0.030
Why?
Patient Outcome Assessment
1
2016
41
0.030
Why?
Evidence-Based Practice
1
2016
85
0.030
Why?
Interviews as Topic
1
2015
139
0.030
Why?
Primary Health Care
1
2016
98
0.030
Why?
Schools
1
2014
46
0.030
Why?
Cotinine
1
2013
5
0.030
Why?
Tobacco Smoke Pollution
1
2013
7
0.030
Why?
Enkephalin, Methionine
1
1993
1
0.030
Why?
Saliva
1
2013
60
0.030
Why?
Killer Cells, Natural
1
1993
49
0.030
Why?
Vital Signs
1
2012
3
0.020
Why?
Work of Breathing
1
2012
6
0.020
Why?
Spirometry
1
2012
12
0.020
Why?
Feasibility Studies
1
2012
233
0.020
Why?
Acute Disease
1
2012
208
0.020
Why?
Program Evaluation
1
2011
137
0.020
Why?
Fluticasone-Salmeterol Drug Combination
1
2010
1
0.020
Why?
Sulfides
1
2010
11
0.020
Why?
Cyclopropanes
1
2010
15
0.020
Why?
Stress, Psychological
1
2012
244
0.020
Why?
Administration, Intranasal
1
2010
27
0.020
Why?
Illinois
1
2009
247
0.020
Why?
Body Mass Index
1
2009
465
0.020
Why?
Sensitivity and Specificity
1
2005
519
0.010
Why?
Vietnam
1
1993
7
0.010
Why?
In Vitro Techniques
1
1993
176
0.010
Why?
Analysis of Variance
1
1993
276
0.010
Why?
Alcoholism
1
1993
74
0.010
Why?
Veterans
1
1993
97
0.010
Why?
Mosnaim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (261)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_